Drug Profile
Research programme: glucokinase stimulants - Yuhan Corporation
Alternative Names: GKA - Yuhan; Glucokinase activators - Yuhan; YH-chem1; YH10561; YH_chem1Latest Information Update: 04 Nov 2017
Price :
$50
*
At a glance
- Originator Yuhan
- Class Small molecules
- Mechanism of Action Glucokinase stimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- Available For Licensing Yes
Highest Development Phases
- No development reported Diabetes mellitus
Most Recent Events
- 04 Nov 2017 No recent reports of development identified for preclinical development in Diabetes-mellitus in South Korea (PO)
- 22 Aug 2012 Preclinical development is ongoing in South Korea
- 18 Jan 2011 Early research in Diabetes mellitus in South Korea (PO)